Combined Shareholders’ Meeting of 28 May 2019

This article or press release has no online content. Please download the associated documents for more information.

Associated Documents

IPSEN-AG-2019-Preliminary-notice-to-the-Meeting-Translation-for-information.pdf
Report-of-the-Board-on-the-proposed-resolutions.pdf
IPSEN_DDR_2018_VA_clean1.pdf
Information-on-voting-rights-on-17-April-2019.pdf
IPSEN-Voting-proxy-form.pdf
Meeting-Notice-Shareholders-Meeting.pdf
Availability-and-consultation-of-preparatory-documentation-for-the-ASM-2019.pdf
Notice-of-the-Shareholders-Meeting-publised-in-the-BALO-in-French.pdf
Notice-of-the-Shareholders-Meeting-published-in-the-BALO-Translation-for-information.pdf
PR-Shareholders-Meeting-IPSEN-S.A.-28-May-2019.pdf
Ipsen-ASM-2019-Results.pdf
Presentation-of-Ipsen-2019-Shareholders-Meeting.pdf

Understanding the true impact of living with FOP

Ipsen Announces Decision to Permanently Discontinue Distribution of NutropinAq® (somatropin) cartridges

Applications now open for the 2023 Golden Ticket Competition

Offering support to those impacted in Turkey & Syria

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023